-
-
-
-
-
-
-
Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 15, 2023
-
-
-
-
-
-
-
Lilly Announces Extension of Tender Offer to Acquire POINT Biopharma
-
-
-
-
-
-
-
POINT Biopharma Global Inc. (PNT) Reports Q3 Loss of $0.86/sh
-
-
-
-
-
-
-
POINT Biopharma Reports Second Quarter 2022 Financial Results and Provides Business Highlights
-
-
-
-
-
-
-
Alok Maskara Named as Next Chief Executive Officer of Luxfer Group
-
-
-
-
-
-
-
CPI Card Group Schedules Second Quarter 2016 Earnings Announcement and Conference Call
-
-
-
-
-
-
1,197,307 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

